nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP2D6—Phentermine—obesity	0.0747	0.142	CbGbCtD
Fesoterodine—CYP2D6—Bupropion—obesity	0.0635	0.121	CbGbCtD
Fesoterodine—CYP3A4—Sibutramine—obesity	0.0627	0.119	CbGbCtD
Fesoterodine—CYP2D6—Methamphetamine—obesity	0.0597	0.113	CbGbCtD
Fesoterodine—ABCB1—Cimetidine—obesity	0.0495	0.094	CbGbCtD
Fesoterodine—CYP3A4—Benzphetamine—obesity	0.0475	0.0902	CbGbCtD
Fesoterodine—CYP2D6—Cimetidine—obesity	0.0466	0.0885	CbGbCtD
Fesoterodine—CYP3A4—Bupropion—obesity	0.0404	0.0767	CbGbCtD
Fesoterodine—CYP3A4—Orlistat—obesity	0.0329	0.0625	CbGbCtD
Fesoterodine—CYP3A4—Cimetidine—obesity	0.0296	0.0563	CbGbCtD
Fesoterodine—CYP3A4—Topiramate—obesity	0.0194	0.0369	CbGbCtD
Fesoterodine—Disopyramide—SLC22A1—obesity	0.00112	1	CrCbGaD
Fesoterodine—Dry mouth—Diethylpropion—obesity	0.0011	0.00427	CcSEcCtD
Fesoterodine—Gastroenteritis—Bupropion—obesity	0.00109	0.00426	CcSEcCtD
Fesoterodine—Dyspepsia—Phentermine—obesity	0.00109	0.00424	CcSEcCtD
Fesoterodine—Headache—Methamphetamine—obesity	0.00108	0.0042	CcSEcCtD
Fesoterodine—Face oedema—Sibutramine—obesity	0.00107	0.00418	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Phentermine—obesity	0.00107	0.00415	CcSEcCtD
Fesoterodine—Fatigue—Phentermine—obesity	0.00106	0.00415	CcSEcCtD
Fesoterodine—Feeling abnormal—Phenylpropanolamine—obesity	0.00106	0.00414	CcSEcCtD
Fesoterodine—Urinary retention—Sibutramine—obesity	0.00106	0.00412	CcSEcCtD
Fesoterodine—Constipation—Phentermine—obesity	0.00106	0.00412	CcSEcCtD
Fesoterodine—Dry skin—Orlistat—obesity	0.00105	0.0041	CcSEcCtD
Fesoterodine—Abdominal pain upper—Orlistat—obesity	0.00105	0.00409	CcSEcCtD
Fesoterodine—Tachycardia—Diethylpropion—obesity	0.00105	0.00409	CcSEcCtD
Fesoterodine—Headache—Benzphetamine—obesity	0.00104	0.00405	CcSEcCtD
Fesoterodine—Diarrhoea—Phendimetrazine—obesity	0.00103	0.00403	CcSEcCtD
Fesoterodine—Gamma-glutamyltransferase increased—Topiramate—obesity	0.00103	0.00403	CcSEcCtD
Fesoterodine—Confusional state—Cimetidine—obesity	0.00103	0.00402	CcSEcCtD
Fesoterodine—Dry skin—Sibutramine—obesity	0.00102	0.00397	CcSEcCtD
Fesoterodine—Dizziness—Phendimetrazine—obesity	0.000998	0.00389	CcSEcCtD
Fesoterodine—Tachycardia—Cimetidine—obesity	0.000997	0.00389	CcSEcCtD
Fesoterodine—Nausea—Benzphetamine—obesity	0.000984	0.00384	CcSEcCtD
Fesoterodine—Urticaria—Phentermine—obesity	0.00098	0.00382	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Sibutramine—obesity	0.000979	0.00382	CcSEcCtD
Fesoterodine—Abdominal pain—Phentermine—obesity	0.000975	0.0038	CcSEcCtD
Fesoterodine—Insomnia—Diethylpropion—obesity	0.000971	0.00379	CcSEcCtD
Fesoterodine—Somnolence—Diethylpropion—obesity	0.000954	0.00372	CcSEcCtD
Fesoterodine—Abdominal discomfort—Orlistat—obesity	0.000951	0.00371	CcSEcCtD
Fesoterodine—Hypersensitivity—Phenylpropanolamine—obesity	0.00095	0.00371	CcSEcCtD
Fesoterodine—Headache—Phendimetrazine—obesity	0.000946	0.00369	CcSEcCtD
Fesoterodine—Dyspepsia—Diethylpropion—obesity	0.000945	0.00369	CcSEcCtD
Fesoterodine—Gastrooesophageal reflux disease—Topiramate—obesity	0.00094	0.00367	CcSEcCtD
Fesoterodine—Angina pectoris—Sibutramine—obesity	0.000935	0.00365	CcSEcCtD
Fesoterodine—Face oedema—Bupropion—obesity	0.000934	0.00364	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Diethylpropion—obesity	0.000927	0.00361	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Orlistat—obesity	0.000921	0.00359	CcSEcCtD
Fesoterodine—Urinary retention—Bupropion—obesity	0.00092	0.00359	CcSEcCtD
Fesoterodine—Constipation—Diethylpropion—obesity	0.000918	0.00358	CcSEcCtD
Fesoterodine—Somnolence—Cimetidine—obesity	0.000908	0.00354	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Topiramate—obesity	0.000898	0.0035	CcSEcCtD
Fesoterodine—Dysuria—Sibutramine—obesity	0.000897	0.0035	CcSEcCtD
Fesoterodine—Nausea—Phendimetrazine—obesity	0.000897	0.0035	CcSEcCtD
Fesoterodine—CHRM3—muscle of abdomen—obesity	0.000895	0.404	CbGeAlD
Fesoterodine—Dry skin—Bupropion—obesity	0.000887	0.00346	CcSEcCtD
Fesoterodine—Asthenia—Phentermine—obesity	0.000885	0.00345	CcSEcCtD
Fesoterodine—Feeling abnormal—Diethylpropion—obesity	0.000884	0.00345	CcSEcCtD
Fesoterodine—Infestation NOS—Orlistat—obesity	0.000884	0.00345	CcSEcCtD
Fesoterodine—Infestation—Orlistat—obesity	0.000884	0.00345	CcSEcCtD
Fesoterodine—Abdominal pain upper—Bupropion—obesity	0.000884	0.00345	CcSEcCtD
Fesoterodine—Fatigue—Cimetidine—obesity	0.00088	0.00343	CcSEcCtD
Fesoterodine—Constipation—Cimetidine—obesity	0.000873	0.00341	CcSEcCtD
Fesoterodine—Urinary tract infection—Orlistat—obesity	0.000859	0.00335	CcSEcCtD
Fesoterodine—Urticaria—Diethylpropion—obesity	0.000853	0.00333	CcSEcCtD
Fesoterodine—Dizziness—Phenylpropanolamine—obesity	0.000853	0.00333	CcSEcCtD
Fesoterodine—Diarrhoea—Phentermine—obesity	0.000844	0.00329	CcSEcCtD
Fesoterodine—Feeling abnormal—Cimetidine—obesity	0.000842	0.00328	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Orlistat—obesity	0.000836	0.00326	CcSEcCtD
Fesoterodine—Urinary tract infection—Sibutramine—obesity	0.000832	0.00324	CcSEcCtD
Fesoterodine—Dizziness—Phentermine—obesity	0.000816	0.00318	CcSEcCtD
Fesoterodine—Rash—Phenylpropanolamine—obesity	0.000813	0.00317	CcSEcCtD
Fesoterodine—Dermatitis—Phenylpropanolamine—obesity	0.000812	0.00317	CcSEcCtD
Fesoterodine—Abdominal discomfort—Bupropion—obesity	0.000802	0.00313	CcSEcCtD
Fesoterodine—Dry eye—Topiramate—obesity	0.000785	0.00306	CcSEcCtD
Fesoterodine—Urinary tract disorder—Orlistat—obesity	0.000784	0.00306	CcSEcCtD
Fesoterodine—Dysuria—Bupropion—obesity	0.000782	0.00305	CcSEcCtD
Fesoterodine—Oedema peripheral—Orlistat—obesity	0.000782	0.00305	CcSEcCtD
Fesoterodine—Urethral disorder—Orlistat—obesity	0.000778	0.00303	CcSEcCtD
Fesoterodine—Rash—Phentermine—obesity	0.000778	0.00303	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Bupropion—obesity	0.000777	0.00303	CcSEcCtD
Fesoterodine—Dermatitis—Phentermine—obesity	0.000777	0.00303	CcSEcCtD
Fesoterodine—Headache—Phentermine—obesity	0.000773	0.00301	CcSEcCtD
Fesoterodine—Nausea—Phenylpropanolamine—obesity	0.000766	0.00299	CcSEcCtD
Fesoterodine—Oedema peripheral—Sibutramine—obesity	0.000757	0.00295	CcSEcCtD
Fesoterodine—Hypersensitivity—Cimetidine—obesity	0.000752	0.00293	CcSEcCtD
Fesoterodine—Infestation NOS—Bupropion—obesity	0.000746	0.00291	CcSEcCtD
Fesoterodine—Infestation—Bupropion—obesity	0.000746	0.00291	CcSEcCtD
Fesoterodine—Diarrhoea—Diethylpropion—obesity	0.000734	0.00286	CcSEcCtD
Fesoterodine—Nausea—Phentermine—obesity	0.000733	0.00286	CcSEcCtD
Fesoterodine—Asthenia—Cimetidine—obesity	0.000733	0.00286	CcSEcCtD
Fesoterodine—Urinary tract infection—Bupropion—obesity	0.000725	0.00283	CcSEcCtD
Fesoterodine—Eye disorder—Sibutramine—obesity	0.000718	0.0028	CcSEcCtD
Fesoterodine—Mediastinal disorder—Orlistat—obesity	0.000715	0.00279	CcSEcCtD
Fesoterodine—Dizziness—Diethylpropion—obesity	0.00071	0.00277	CcSEcCtD
Fesoterodine—Diarrhoea—Cimetidine—obesity	0.000699	0.00273	CcSEcCtD
Fesoterodine—Gastroenteritis—Topiramate—obesity	0.000696	0.00271	CcSEcCtD
Fesoterodine—Mental disorder—Orlistat—obesity	0.000695	0.00271	CcSEcCtD
Fesoterodine—Flatulence—Orlistat—obesity	0.000681	0.00266	CcSEcCtD
Fesoterodine—Rash—Diethylpropion—obesity	0.000677	0.00264	CcSEcCtD
Fesoterodine—Dysgeusia—Orlistat—obesity	0.000677	0.00264	CcSEcCtD
Fesoterodine—Dermatitis—Diethylpropion—obesity	0.000676	0.00264	CcSEcCtD
Fesoterodine—Dizziness—Cimetidine—obesity	0.000675	0.00263	CcSEcCtD
Fesoterodine—Headache—Diethylpropion—obesity	0.000672	0.00262	CcSEcCtD
Fesoterodine—Back pain—Orlistat—obesity	0.000668	0.00261	CcSEcCtD
Fesoterodine—Urinary tract disorder—Bupropion—obesity	0.000661	0.00258	CcSEcCtD
Fesoterodine—Oedema peripheral—Bupropion—obesity	0.00066	0.00257	CcSEcCtD
Fesoterodine—Flatulence—Sibutramine—obesity	0.000659	0.00257	CcSEcCtD
Fesoterodine—Urethral disorder—Bupropion—obesity	0.000656	0.00256	CcSEcCtD
Fesoterodine—Dysgeusia—Sibutramine—obesity	0.000655	0.00255	CcSEcCtD
Fesoterodine—Vision blurred—Orlistat—obesity	0.000651	0.00254	CcSEcCtD
Fesoterodine—Back pain—Sibutramine—obesity	0.000647	0.00252	CcSEcCtD
Fesoterodine—Rash—Cimetidine—obesity	0.000644	0.00251	CcSEcCtD
Fesoterodine—Dermatitis—Cimetidine—obesity	0.000643	0.00251	CcSEcCtD
Fesoterodine—Headache—Cimetidine—obesity	0.00064	0.0025	CcSEcCtD
Fesoterodine—Nausea—Diethylpropion—obesity	0.000638	0.00249	CcSEcCtD
Fesoterodine—Angioedema—Orlistat—obesity	0.000631	0.00246	CcSEcCtD
Fesoterodine—Vision blurred—Sibutramine—obesity	0.00063	0.00246	CcSEcCtD
Fesoterodine—Eye disorder—Bupropion—obesity	0.000626	0.00244	CcSEcCtD
Fesoterodine—Cardiac disorder—Bupropion—obesity	0.000621	0.00242	CcSEcCtD
Fesoterodine—Vertigo—Orlistat—obesity	0.000621	0.00242	CcSEcCtD
Fesoterodine—Angioedema—Sibutramine—obesity	0.000611	0.00238	CcSEcCtD
Fesoterodine—Palpitations—Orlistat—obesity	0.000611	0.00238	CcSEcCtD
Fesoterodine—Nausea—Cimetidine—obesity	0.000607	0.00237	CcSEcCtD
Fesoterodine—Mediastinal disorder—Bupropion—obesity	0.000603	0.00235	CcSEcCtD
Fesoterodine—Cough—Orlistat—obesity	0.000603	0.00235	CcSEcCtD
Fesoterodine—Vertigo—Sibutramine—obesity	0.000601	0.00234	CcSEcCtD
Fesoterodine—Face oedema—Topiramate—obesity	0.000595	0.00232	CcSEcCtD
Fesoterodine—Palpitations—Sibutramine—obesity	0.000591	0.0023	CcSEcCtD
Fesoterodine—Chest pain—Orlistat—obesity	0.000588	0.00229	CcSEcCtD
Fesoterodine—Mental disorder—Bupropion—obesity	0.000587	0.00229	CcSEcCtD
Fesoterodine—Urinary retention—Topiramate—obesity	0.000586	0.00229	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000584	0.00228	CcSEcCtD
Fesoterodine—Cough—Sibutramine—obesity	0.000583	0.00228	CcSEcCtD
Fesoterodine—Dry mouth—Orlistat—obesity	0.000575	0.00224	CcSEcCtD
Fesoterodine—Flatulence—Bupropion—obesity	0.000574	0.00224	CcSEcCtD
Fesoterodine—Dysgeusia—Bupropion—obesity	0.000571	0.00223	CcSEcCtD
Fesoterodine—Chest pain—Sibutramine—obesity	0.000569	0.00222	CcSEcCtD
Fesoterodine—Back pain—Bupropion—obesity	0.000564	0.0022	CcSEcCtD
Fesoterodine—Abdominal pain upper—Topiramate—obesity	0.000563	0.0022	CcSEcCtD
Fesoterodine—Infection—Orlistat—obesity	0.00056	0.00218	CcSEcCtD
Fesoterodine—Dry mouth—Sibutramine—obesity	0.000557	0.00217	CcSEcCtD
Fesoterodine—Nervous system disorder—Orlistat—obesity	0.000553	0.00216	CcSEcCtD
Fesoterodine—Confusional state—Sibutramine—obesity	0.00055	0.00215	CcSEcCtD
Fesoterodine—Vision blurred—Bupropion—obesity	0.000549	0.00214	CcSEcCtD
Fesoterodine—Skin disorder—Orlistat—obesity	0.000548	0.00214	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Topiramate—obesity	0.000544	0.00212	CcSEcCtD
Fesoterodine—Infection—Sibutramine—obesity	0.000542	0.00211	CcSEcCtD
Fesoterodine—Angioedema—Bupropion—obesity	0.000533	0.00208	CcSEcCtD
Fesoterodine—Tachycardia—Sibutramine—obesity	0.000533	0.00208	CcSEcCtD
Fesoterodine—Skin disorder—Sibutramine—obesity	0.00053	0.00207	CcSEcCtD
Fesoterodine—Vertigo—Bupropion—obesity	0.000524	0.00204	CcSEcCtD
Fesoterodine—Angina pectoris—Topiramate—obesity	0.000519	0.00203	CcSEcCtD
Fesoterodine—Palpitations—Bupropion—obesity	0.000515	0.00201	CcSEcCtD
Fesoterodine—Abdominal discomfort—Topiramate—obesity	0.000511	0.00199	CcSEcCtD
Fesoterodine—Insomnia—Orlistat—obesity	0.00051	0.00199	CcSEcCtD
Fesoterodine—Cough—Bupropion—obesity	0.000509	0.00198	CcSEcCtD
Fesoterodine—Dysuria—Topiramate—obesity	0.000498	0.00194	CcSEcCtD
Fesoterodine—Dyspepsia—Orlistat—obesity	0.000496	0.00194	CcSEcCtD
Fesoterodine—Chest pain—Bupropion—obesity	0.000496	0.00194	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Topiramate—obesity	0.000495	0.00193	CcSEcCtD
Fesoterodine—Insomnia—Sibutramine—obesity	0.000494	0.00193	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000493	0.00192	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Orlistat—obesity	0.000487	0.0019	CcSEcCtD
Fesoterodine—Fatigue—Orlistat—obesity	0.000486	0.0019	CcSEcCtD
Fesoterodine—Dry mouth—Bupropion—obesity	0.000485	0.00189	CcSEcCtD
Fesoterodine—Somnolence—Sibutramine—obesity	0.000485	0.00189	CcSEcCtD
Fesoterodine—Dyspepsia—Sibutramine—obesity	0.00048	0.00187	CcSEcCtD
Fesoterodine—Confusional state—Bupropion—obesity	0.00048	0.00187	CcSEcCtD
Fesoterodine—Infestation—Topiramate—obesity	0.000475	0.00185	CcSEcCtD
Fesoterodine—Infestation NOS—Topiramate—obesity	0.000475	0.00185	CcSEcCtD
Fesoterodine—Infection—Bupropion—obesity	0.000473	0.00184	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Sibutramine—obesity	0.000471	0.00184	CcSEcCtD
Fesoterodine—Constipation—Sibutramine—obesity	0.000467	0.00182	CcSEcCtD
Fesoterodine—Nervous system disorder—Bupropion—obesity	0.000467	0.00182	CcSEcCtD
Fesoterodine—Feeling abnormal—Orlistat—obesity	0.000465	0.00181	CcSEcCtD
Fesoterodine—Tachycardia—Bupropion—obesity	0.000464	0.00181	CcSEcCtD
Fesoterodine—Skin disorder—Bupropion—obesity	0.000462	0.0018	CcSEcCtD
Fesoterodine—Urinary tract infection—Topiramate—obesity	0.000462	0.0018	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Orlistat—obesity	0.000461	0.0018	CcSEcCtD
Fesoterodine—Feeling abnormal—Sibutramine—obesity	0.00045	0.00175	CcSEcCtD
Fesoterodine—Urticaria—Orlistat—obesity	0.000448	0.00175	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Sibutramine—obesity	0.000446	0.00174	CcSEcCtD
Fesoterodine—Abdominal pain—Orlistat—obesity	0.000446	0.00174	CcSEcCtD
Fesoterodine—Urticaria—Sibutramine—obesity	0.000433	0.00169	CcSEcCtD
Fesoterodine—Abdominal pain—Sibutramine—obesity	0.000431	0.00168	CcSEcCtD
Fesoterodine—Insomnia—Bupropion—obesity	0.00043	0.00168	CcSEcCtD
Fesoterodine—Somnolence—Bupropion—obesity	0.000423	0.00165	CcSEcCtD
Fesoterodine—Urinary tract disorder—Topiramate—obesity	0.000421	0.00164	CcSEcCtD
Fesoterodine—Oedema peripheral—Topiramate—obesity	0.00042	0.00164	CcSEcCtD
Fesoterodine—Dyspepsia—Bupropion—obesity	0.000419	0.00163	CcSEcCtD
Fesoterodine—Urethral disorder—Topiramate—obesity	0.000418	0.00163	CcSEcCtD
Fesoterodine—Hypersensitivity—Orlistat—obesity	0.000415	0.00162	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Bupropion—obesity	0.000411	0.0016	CcSEcCtD
Fesoterodine—Fatigue—Bupropion—obesity	0.00041	0.0016	CcSEcCtD
Fesoterodine—Constipation—Bupropion—obesity	0.000407	0.00159	CcSEcCtD
Fesoterodine—Asthenia—Orlistat—obesity	0.000405	0.00158	CcSEcCtD
Fesoterodine—Hypersensitivity—Sibutramine—obesity	0.000402	0.00157	CcSEcCtD
Fesoterodine—Pruritus—Orlistat—obesity	0.000399	0.00156	CcSEcCtD
Fesoterodine—Eye disorder—Topiramate—obesity	0.000399	0.00156	CcSEcCtD
Fesoterodine—Cardiac disorder—Topiramate—obesity	0.000396	0.00154	CcSEcCtD
Fesoterodine—Feeling abnormal—Bupropion—obesity	0.000392	0.00153	CcSEcCtD
Fesoterodine—Asthenia—Sibutramine—obesity	0.000392	0.00153	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Bupropion—obesity	0.000389	0.00152	CcSEcCtD
Fesoterodine—Pruritus—Sibutramine—obesity	0.000386	0.00151	CcSEcCtD
Fesoterodine—Diarrhoea—Orlistat—obesity	0.000386	0.0015	CcSEcCtD
Fesoterodine—Mediastinal disorder—Topiramate—obesity	0.000384	0.0015	CcSEcCtD
Fesoterodine—Urticaria—Bupropion—obesity	0.000378	0.00147	CcSEcCtD
Fesoterodine—Abdominal pain—Bupropion—obesity	0.000376	0.00147	CcSEcCtD
Fesoterodine—Mental disorder—Topiramate—obesity	0.000374	0.00146	CcSEcCtD
Fesoterodine—Diarrhoea—Sibutramine—obesity	0.000373	0.00146	CcSEcCtD
Fesoterodine—Dizziness—Orlistat—obesity	0.000373	0.00145	CcSEcCtD
Fesoterodine—Flatulence—Topiramate—obesity	0.000366	0.00143	CcSEcCtD
Fesoterodine—Dysgeusia—Topiramate—obesity	0.000364	0.00142	CcSEcCtD
Fesoterodine—Dizziness—Sibutramine—obesity	0.000361	0.00141	CcSEcCtD
Fesoterodine—Back pain—Topiramate—obesity	0.000359	0.0014	CcSEcCtD
Fesoterodine—Rash—Orlistat—obesity	0.000356	0.00139	CcSEcCtD
Fesoterodine—Dermatitis—Orlistat—obesity	0.000355	0.00139	CcSEcCtD
Fesoterodine—Headache—Orlistat—obesity	0.000353	0.00138	CcSEcCtD
Fesoterodine—Hypersensitivity—Bupropion—obesity	0.00035	0.00137	CcSEcCtD
Fesoterodine—Vision blurred—Topiramate—obesity	0.00035	0.00137	CcSEcCtD
Fesoterodine—Rash—Sibutramine—obesity	0.000344	0.00134	CcSEcCtD
Fesoterodine—Dermatitis—Sibutramine—obesity	0.000344	0.00134	CcSEcCtD
Fesoterodine—Headache—Sibutramine—obesity	0.000342	0.00133	CcSEcCtD
Fesoterodine—Asthenia—Bupropion—obesity	0.000341	0.00133	CcSEcCtD
Fesoterodine—Pruritus—Bupropion—obesity	0.000337	0.00131	CcSEcCtD
Fesoterodine—Nausea—Orlistat—obesity	0.000335	0.00131	CcSEcCtD
Fesoterodine—Vertigo—Topiramate—obesity	0.000334	0.0013	CcSEcCtD
Fesoterodine—Palpitations—Topiramate—obesity	0.000328	0.00128	CcSEcCtD
Fesoterodine—Diarrhoea—Bupropion—obesity	0.000325	0.00127	CcSEcCtD
Fesoterodine—Nausea—Sibutramine—obesity	0.000324	0.00126	CcSEcCtD
Fesoterodine—Cough—Topiramate—obesity	0.000324	0.00126	CcSEcCtD
Fesoterodine—Chest pain—Topiramate—obesity	0.000316	0.00123	CcSEcCtD
Fesoterodine—Dizziness—Bupropion—obesity	0.000315	0.00123	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000314	0.00122	CcSEcCtD
Fesoterodine—Dry mouth—Topiramate—obesity	0.000309	0.00121	CcSEcCtD
Fesoterodine—Confusional state—Topiramate—obesity	0.000306	0.00119	CcSEcCtD
Fesoterodine—Infection—Topiramate—obesity	0.000301	0.00117	CcSEcCtD
Fesoterodine—Rash—Bupropion—obesity	0.0003	0.00117	CcSEcCtD
Fesoterodine—Dermatitis—Bupropion—obesity	0.0003	0.00117	CcSEcCtD
Fesoterodine—Headache—Bupropion—obesity	0.000298	0.00116	CcSEcCtD
Fesoterodine—Nervous system disorder—Topiramate—obesity	0.000297	0.00116	CcSEcCtD
Fesoterodine—Tachycardia—Topiramate—obesity	0.000296	0.00115	CcSEcCtD
Fesoterodine—Skin disorder—Topiramate—obesity	0.000294	0.00115	CcSEcCtD
Fesoterodine—Nausea—Bupropion—obesity	0.000283	0.0011	CcSEcCtD
Fesoterodine—Insomnia—Topiramate—obesity	0.000274	0.00107	CcSEcCtD
Fesoterodine—Somnolence—Topiramate—obesity	0.000269	0.00105	CcSEcCtD
Fesoterodine—Dyspepsia—Topiramate—obesity	0.000267	0.00104	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Topiramate—obesity	0.000262	0.00102	CcSEcCtD
Fesoterodine—Fatigue—Topiramate—obesity	0.000261	0.00102	CcSEcCtD
Fesoterodine—Constipation—Topiramate—obesity	0.000259	0.00101	CcSEcCtD
Fesoterodine—Feeling abnormal—Topiramate—obesity	0.00025	0.000974	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Topiramate—obesity	0.000248	0.000967	CcSEcCtD
Fesoterodine—Urticaria—Topiramate—obesity	0.000241	0.000939	CcSEcCtD
Fesoterodine—Abdominal pain—Topiramate—obesity	0.00024	0.000935	CcSEcCtD
Fesoterodine—Hypersensitivity—Topiramate—obesity	0.000223	0.000871	CcSEcCtD
Fesoterodine—Asthenia—Topiramate—obesity	0.000217	0.000848	CcSEcCtD
Fesoterodine—Pruritus—Topiramate—obesity	0.000214	0.000836	CcSEcCtD
Fesoterodine—Diarrhoea—Topiramate—obesity	0.000207	0.000809	CcSEcCtD
Fesoterodine—Dizziness—Topiramate—obesity	0.0002	0.000782	CcSEcCtD
Fesoterodine—Rash—Topiramate—obesity	0.000191	0.000745	CcSEcCtD
Fesoterodine—Dermatitis—Topiramate—obesity	0.000191	0.000745	CcSEcCtD
Fesoterodine—Headache—Topiramate—obesity	0.00019	0.000741	CcSEcCtD
Fesoterodine—Nausea—Topiramate—obesity	0.00018	0.000702	CcSEcCtD
Fesoterodine—CHRM2—cardiovascular system—obesity	0.00012	0.0541	CbGeAlD
Fesoterodine—CYP2D6—hindbrain—obesity	0.000113	0.051	CbGeAlD
Fesoterodine—CHRM1—cardiovascular system—obesity	0.000109	0.0492	CbGeAlD
Fesoterodine—CHRM3—adipose tissue—obesity	8.61e-05	0.0389	CbGeAlD
Fesoterodine—CHRM2—endocrine gland—obesity	8.22e-05	0.0371	CbGeAlD
Fesoterodine—CHRM3—digestive system—obesity	8.1e-05	0.0366	CbGeAlD
Fesoterodine—CHRM1—endocrine gland—obesity	7.48e-05	0.0338	CbGeAlD
Fesoterodine—CHRM3—endocrine gland—obesity	6.7e-05	0.0302	CbGeAlD
Fesoterodine—ABCB1—islet of Langerhans—obesity	5.25e-05	0.0237	CbGeAlD
Fesoterodine—ABCB1—respiratory system—obesity	4.96e-05	0.0224	CbGeAlD
Fesoterodine—CYP3A4—digestive system—obesity	4.45e-05	0.0201	CbGeAlD
Fesoterodine—CYP2D6—digestive system—obesity	4.38e-05	0.0198	CbGeAlD
Fesoterodine—ABCB1—adrenal cortex—obesity	4.16e-05	0.0188	CbGeAlD
Fesoterodine—ABCB1—cardiovascular system—obesity	3.8e-05	0.0171	CbGeAlD
Fesoterodine—CYP3A4—endocrine gland—obesity	3.68e-05	0.0166	CbGeAlD
Fesoterodine—CYP2D6—endocrine gland—obesity	3.62e-05	0.0163	CbGeAlD
Fesoterodine—ABCB1—pituitary gland—obesity	3.36e-05	0.0152	CbGeAlD
Fesoterodine—ABCB1—adipose tissue—obesity	3.35e-05	0.0151	CbGeAlD
Fesoterodine—CYP3A4—liver—obesity	3.32e-05	0.015	CbGeAlD
Fesoterodine—CYP2D6—liver—obesity	3.26e-05	0.0147	CbGeAlD
Fesoterodine—ABCB1—digestive system—obesity	3.15e-05	0.0142	CbGeAlD
Fesoterodine—ABCB1—adrenal gland—obesity	3e-05	0.0136	CbGeAlD
Fesoterodine—ABCB1—endocrine gland—obesity	2.6e-05	0.0118	CbGeAlD
Fesoterodine—ABCB1—liver—obesity	2.35e-05	0.0106	CbGeAlD
Fesoterodine—CHRM5—Signaling by GPCR—PIK3CA—obesity	8.24e-06	3.85e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS2—obesity	8.2e-06	3.83e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AGT—obesity	8.19e-06	3.83e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—DPYD—obesity	8.18e-06	3.82e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—COMT—obesity	8.17e-06	3.82e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—obesity	8.13e-06	3.8e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LEP—obesity	8.13e-06	3.8e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LEP—obesity	8.1e-06	3.79e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—obesity	8.1e-06	3.79e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GNB3—obesity	8.06e-06	3.77e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARGC1A—obesity	8.06e-06	3.77e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CAV1—obesity	8.05e-06	3.76e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOA1—obesity	8.04e-06	3.76e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CAV1—obesity	8.03e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—obesity	8.03e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LEP—obesity	8.03e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—obesity	8.02e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOA1—obesity	8.01e-06	3.74e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MTOR—obesity	7.98e-06	3.73e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3CB—obesity	7.98e-06	3.73e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CAV1—obesity	7.95e-06	3.72e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOA1—obesity	7.93e-06	3.71e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PRKAR2B—obesity	7.87e-06	3.68e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GNAS—obesity	7.85e-06	3.67e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—DCN—obesity	7.81e-06	3.65e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ESR1—obesity	7.76e-06	3.63e-05	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—AKT1—obesity	7.74e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ESR1—obesity	7.74e-06	3.62e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—COMT—obesity	7.7e-06	3.6e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CD—obesity	7.69e-06	3.59e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOB—obesity	7.68e-06	3.59e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PRKCB—obesity	7.67e-06	3.58e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—F2—obesity	7.67e-06	3.58e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ESR1—obesity	7.66e-06	3.58e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—F2—obesity	7.64e-06	3.57e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PRKCB—obesity	7.64e-06	3.57e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—obesity	7.62e-06	3.56e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CPT1A—obesity	7.6e-06	3.55e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GNB3—obesity	7.59e-06	3.55e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARGC1A—obesity	7.59e-06	3.55e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALB—obesity	7.59e-06	3.55e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—BAD—obesity	7.58e-06	3.54e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—F2—obesity	7.57e-06	3.54e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PRKCB—obesity	7.57e-06	3.54e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—obesity	7.56e-06	3.53e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—BAD—obesity	7.55e-06	3.53e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—BAD—obesity	7.48e-06	3.5e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NAMPT—obesity	7.45e-06	3.48e-05	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—AKT1—obesity	7.41e-06	3.46e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LIPC—obesity	7.41e-06	3.46e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCK—obesity	7.41e-06	3.46e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GNAS—obesity	7.39e-06	3.46e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOC3—obesity	7.36e-06	3.44e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CG—obesity	7.34e-06	3.43e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—LPL—obesity	7.34e-06	3.43e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CG—obesity	7.31e-06	3.42e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—obesity	7.3e-06	3.41e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—obesity	7.26e-06	3.39e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3R1—obesity	7.26e-06	3.39e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS1—obesity	7.25e-06	3.39e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—obesity	7.25e-06	3.39e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CG—obesity	7.24e-06	3.39e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOB—obesity	7.24e-06	3.38e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS1—obesity	7.23e-06	3.38e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS1—obesity	7.16e-06	3.35e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GPX1—obesity	7.16e-06	3.35e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CETP—obesity	7.15e-06	3.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SDC1—obesity	7.07e-06	3.3e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MAPK8—obesity	7.05e-06	3.29e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—AKT1—obesity	7.03e-06	3.29e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—POMC—obesity	6.98e-06	3.26e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CD36—obesity	6.97e-06	3.26e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—POMC—obesity	6.96e-06	3.25e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKR1C3—obesity	6.95e-06	3.25e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—INS—obesity	6.95e-06	3.25e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—obesity	6.94e-06	3.24e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—INS—obesity	6.92e-06	3.24e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—LPL—obesity	6.91e-06	3.23e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—POMC—obesity	6.89e-06	3.22e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—INS—obesity	6.86e-06	3.2e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SCARB1—obesity	6.84e-06	3.2e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL2—obesity	6.83e-06	3.19e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL2—obesity	6.81e-06	3.18e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MAPK8—obesity	6.75e-06	3.15e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL2—obesity	6.75e-06	3.15e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GPX1—obesity	6.74e-06	3.15e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—AKT1—obesity	6.73e-06	3.15e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1—obesity	6.72e-06	3.14e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT2—obesity	6.71e-06	3.14e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CB—obesity	6.7e-06	3.13e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1—obesity	6.7e-06	3.13e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT2—obesity	6.69e-06	3.13e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SREBF1—obesity	6.64e-06	3.11e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—obesity	6.64e-06	3.1e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1—obesity	6.63e-06	3.1e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT2—obesity	6.63e-06	3.1e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—obesity	6.61e-06	3.09e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CD36—obesity	6.57e-06	3.07e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARA—obesity	6.48e-06	3.03e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GOT2—obesity	6.46e-06	3.02e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CD—obesity	6.45e-06	3.01e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—STAT3—obesity	6.44e-06	3.01e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CD—obesity	6.43e-06	3.01e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	6.39e-06	2.99e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SERPINE1—obesity	6.38e-06	2.98e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	6.37e-06	2.98e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CD—obesity	6.37e-06	2.98e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SERPINE1—obesity	6.36e-06	2.97e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—FASN—obesity	6.32e-06	2.96e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	6.31e-06	2.95e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—BCHE—obesity	6.3e-06	2.94e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SERPINE1—obesity	6.3e-06	2.94e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AGT—obesity	6.28e-06	2.93e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—obesity	6.22e-06	2.91e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TYK2—obesity	6.2e-06	2.9e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TYK2—obesity	6.19e-06	2.89e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—STAT3—obesity	6.17e-06	2.88e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RHOA—obesity	6.15e-06	2.88e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—obesity	6.15e-06	2.87e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RHOA—obesity	6.13e-06	2.87e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TYK2—obesity	6.13e-06	2.86e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARA—obesity	6.11e-06	2.85e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CAV1—obesity	6.09e-06	2.85e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3R1—obesity	6.09e-06	2.85e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—obesity	6.09e-06	2.85e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOA1—obesity	6.08e-06	2.84e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2E1—obesity	6.08e-06	2.84e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RHOA—obesity	6.07e-06	2.84e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3R1—obesity	6.07e-06	2.84e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—obesity	6.07e-06	2.84e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—obesity	6.01e-06	2.81e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3R1—obesity	6.01e-06	2.81e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NQO1—obesity	6.01e-06	2.81e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MYC—obesity	5.99e-06	2.8e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFB1—obesity	5.97e-06	2.79e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AGT—obesity	5.91e-06	2.76e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PIK3CA—obesity	5.8e-06	2.71e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—obesity	5.79e-06	2.71e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PIK3CA—obesity	5.78e-06	2.7e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCG—obesity	5.76e-06	2.69e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC2A4—obesity	5.76e-06	2.69e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CAV1—obesity	5.74e-06	2.68e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MYC—obesity	5.73e-06	2.68e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOA1—obesity	5.73e-06	2.68e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PIK3CA—obesity	5.73e-06	2.68e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFB1—obesity	5.72e-06	2.67e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYCS—obesity	5.68e-06	2.66e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MTOR—obesity	5.62e-06	2.63e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CB—obesity	5.62e-06	2.63e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MTOR—obesity	5.6e-06	2.62e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CB—obesity	5.6e-06	2.62e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GOT1—obesity	5.58e-06	2.61e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GGT1—obesity	5.58e-06	2.61e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CG—obesity	5.55e-06	2.59e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MTOR—obesity	5.55e-06	2.59e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CB—obesity	5.55e-06	2.59e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NCOA1—obesity	5.49e-06	2.57e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP19A1—obesity	5.42e-06	2.53e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—STK11—obesity	5.42e-06	2.53e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARG—obesity	5.36e-06	2.5e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—POMC—obesity	5.28e-06	2.47e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—INS—obesity	5.25e-06	2.46e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CG—obesity	5.23e-06	2.44e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—AKT1—obesity	5.22e-06	2.44e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—AKT1—obesity	5.2e-06	2.43e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—AKT1—obesity	5.15e-06	2.41e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—obesity	5.14e-06	2.4e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—obesity	5.12e-06	2.39e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PIK3CA—obesity	5.08e-06	2.38e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—obesity	5.07e-06	2.37e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARG—obesity	5.05e-06	2.36e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—COMT—obesity	5.03e-06	2.35e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—POMC—obesity	4.98e-06	2.33e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GNB3—obesity	4.96e-06	2.32e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARGC1A—obesity	4.96e-06	2.32e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—INS—obesity	4.95e-06	2.31e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—obesity	4.94e-06	2.31e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—obesity	4.89e-06	2.28e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CD—obesity	4.88e-06	2.28e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—obesity	4.87e-06	2.28e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3CA—obesity	4.87e-06	2.27e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GNAS—obesity	4.83e-06	2.26e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—obesity	4.82e-06	2.25e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALB—obesity	4.82e-06	2.25e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MAPK8—obesity	4.75e-06	2.22e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—AKT1—obesity	4.74e-06	2.22e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MAPK8—obesity	4.74e-06	2.21e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOB—obesity	4.73e-06	2.21e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—AKT1—obesity	4.72e-06	2.21e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MAPK8—obesity	4.69e-06	2.19e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—AKT1—obesity	4.68e-06	2.19e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—obesity	4.61e-06	2.15e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3R1—obesity	4.61e-06	2.15e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CD—obesity	4.6e-06	2.15e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALB—obesity	4.54e-06	2.12e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LPL—obesity	4.52e-06	2.11e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—obesity	4.5e-06	2.1e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPX1—obesity	4.41e-06	2.06e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—STAT3—obesity	4.34e-06	2.03e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3R1—obesity	4.34e-06	2.03e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—obesity	4.34e-06	2.03e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—STAT3—obesity	4.33e-06	2.02e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—obesity	4.31e-06	2.01e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CD36—obesity	4.29e-06	2.01e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—STAT3—obesity	4.29e-06	2e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CB—obesity	4.25e-06	1.99e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—obesity	4.21e-06	1.97e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AKT1—obesity	4.15e-06	1.94e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CA—obesity	4.09e-06	1.91e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—obesity	4.07e-06	1.9e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MYC—obesity	4.04e-06	1.89e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFB1—obesity	4.03e-06	1.88e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MYC—obesity	4.02e-06	1.88e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFB1—obesity	4.01e-06	1.88e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CB—obesity	4.01e-06	1.87e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARA—obesity	3.99e-06	1.87e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MYC—obesity	3.99e-06	1.86e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AKT1—obesity	3.98e-06	1.86e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFB1—obesity	3.98e-06	1.86e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—obesity	3.97e-06	1.86e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AGT—obesity	3.87e-06	1.81e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—obesity	3.79e-06	1.77e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CAV1—obesity	3.75e-06	1.75e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOA1—obesity	3.75e-06	1.75e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CA—obesity	3.43e-06	1.6e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CG—obesity	3.42e-06	1.6e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CA—obesity	3.42e-06	1.6e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CA—obesity	3.38e-06	1.58e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—AKT1—obesity	3.34e-06	1.56e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARG—obesity	3.3e-06	1.54e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—POMC—obesity	3.25e-06	1.52e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—INS—obesity	3.24e-06	1.51e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—obesity	3.03e-06	1.42e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—obesity	3.03e-06	1.41e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CD—obesity	3.01e-06	1.4e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—obesity	3e-06	1.4e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALB—obesity	2.97e-06	1.39e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—obesity	2.84e-06	1.33e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3R1—obesity	2.84e-06	1.33e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT1—obesity	2.8e-06	1.31e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT1—obesity	2.79e-06	1.3e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT1—obesity	2.76e-06	1.29e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CB—obesity	2.62e-06	1.22e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—obesity	2.6e-06	1.21e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CA—obesity	2.59e-06	1.21e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CA—obesity	2.44e-06	1.14e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AKT1—obesity	2.12e-06	9.9e-06	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AKT1—obesity	2e-06	9.33e-06	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CA—obesity	1.6e-06	7.46e-06	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKT1—obesity	1.3e-06	6.1e-06	CbGpPWpGaD
